NM_001369.3(DNAH5):c.10951G>A (p.Asp3651Asn) AND Primary ciliary dyskinesia

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Dec 31, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004510826.1

Allele description [Variation Report for NM_001369.3(DNAH5):c.10951G>A (p.Asp3651Asn)]

NM_001369.3(DNAH5):c.10951G>A (p.Asp3651Asn)

Gene:

DNAH5:dynein axonemal heavy chain 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5p15.2

Genomic location:

Preferred name:

NM_001369.3(DNAH5):c.10951G>A (p.Asp3651Asn)

HGVS:

NC_000005.10:g.13752211C>T
NG_013081.2:g.197270G>A
NM_001369.3:c.10951G>AMANE SELECT
NP_001360.1:p.Asp3651Asn
NC_000005.9:g.13752320C>T
NM_001369.2:c.10951G>A

Protein change:

D3651N

Molecular consequence:

NM_001369.3:c.10951G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Primary ciliary dyskinesia
Synonyms:: Ciliary dyskinesia
Identifiers:: MONDO: MONDO:0016575; MedGen: C0008780; OMIM: PS244400; Human Phenotype Ontology: HP:0012265

Recent activity

Clear Turn Off Turn On

Cercopithecus lhoesti BST2 gene for bone marrow stromal antigen 2, complete cds
Cercopithecus lhoesti BST2 gene for bone marrow stromal antigen 2, complete cds
gi|939106160|dbj|LC012313.1|

Nucleotide
Schizosaccharomyces pombe RNA-binding protein Prp24 (prp24), mRNA
Schizosaccharomyces pombe RNA-binding protein Prp24 (prp24), mRNA
gi|2745686129|ref|NM_001022646.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV005017493	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Dec 31, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV005017493

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Dec 31, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV005017493.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.D3651N variant (also known as c.10951G>A), located in coding exon 64 of the DNAH5 gene, results from a G to A substitution at nucleotide position 10951. The aspartic acid at codon 3651 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 16, 2024

ClinVar

Relating variation to medicine